The changes state that any conventional attack on Russia, aided by a nuclear power, could be considered to be a joint attack
world3 days ago
Scientists have developed what is being seen as a groundbreaking "cancer-killing pill" — named in the honour of a nine-year-old girl who died of the deadly disease.
Researchers at City of Hope, a cancer research centre in the US, have come up with a "targeted chemotherapy" that appears to “annihilate” all solid tumours without affecting healthy cells, according to an official statement.
The drug has been in development for 20 years, and is now undergoing pre-clinical research in the US, Sky News reported.
The therapy is called AOH1996 — and uses the initials and the year of birth of Indiana's Anna Olivia Healey, who died in 2005 of a rare cancer, the statement added.
According to the City of Hope, AOH1996 works by targeting a cancerous variant of PCNA (proliferating cell nuclear antigen) and stops the growth and spread of human cancer cells. PCNA is a protein which, in its mutated form, is critical in the replication of DNA and repair of all expanding tumours.
Professor Linda Malkas of City of Hope's Department of Molecular Diagnostics and Experimental Therapeutics explained that most targeted cancer therapies tend to focus on a single pathway while treating the disease. Malkas added that AOH1996 enables the cancer to mutate and become resistant.
However, PCNA is “like a major airline terminal hub containing multiple plane gates,” said Malkas, who is also the senior author of the new study published in the journal Cell Chemical Biology. The study explains the functioning of cancer therapy.
Malkas said, “Data suggests PCNA is uniquely altered in cancer cells, and this fact allowed us to design a drug that targeted only the form of PCNA in cancer cells.” She added that the pill is “like a snowstorm that closes a key airline hub, shutting down all flights in and out only in planes carrying cancer cells”.
According to Malkas, AOH1996 has shown “promising results” and can suppress tumour growth “as a monotherapy or combination treatment in cell and animal models without resulting in toxicity”.
Researchers have observed that AOH1996 has been effective in treating cells derived from brain, prostate, breast, cervical, skin, and ovarian cancers in preclinical research.
“We were too late to help Anna, but we could help others like her,” Malkas said. “I always say when you see me, there’s a small nine-year-old girl sitting on my right shoulder. She’s my touchstone.”
Malkas, according to City of Hope, had met Anna’s father, Steve, just months before the little girl died.
Anna was born in 1996 in Indianapolis, US, and was suffering from neuroblastoma, a childhood cancer. Anna battled the disease for five years. She breathed her last in 2005.
ALSO READ:
The changes state that any conventional attack on Russia, aided by a nuclear power, could be considered to be a joint attack
world3 days ago
The country launched a probe in March 2021 into WhatsApp's privacy policy, which allowed data sharing with Facebook and its units, sparking global backlash
world3 days ago
This time around, Trump wants the Senate to give up that gatekeeping role and allow him to make 'recess appointments'
world4 days ago
Police allege the offences took place between 2001 and 2019 against 8 victims; the youngest was 17 at the time of the offence
world4 days ago
The two countries have a mutual defence treaty dating back to 1951, which could be invoked if either side came under attack, including in the South China Sea
world4 days ago
Nigerian President Bola Ahmed Tinubu conferred the Grand Commander of the Order of Niger on Narendra Modi in Abuja on Sunday
world4 days ago
The titleholder's winning answer focused on using each individual's strengths
world5 days ago
The suspects would be interrogated jointly with the Shin Bet internal security agency, police said
world5 days ago